{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:23:32Z","timestamp":1790277812497,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Funds from Tehran University of Medical Sciences","award":["22976"],"award-info":[{"award-number":["22976"]}]},{"name":"Research Funds from Tehran University of Medical Sciences","award":["22979"],"award-info":[{"award-number":["22979"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jns.2015.11.021","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T21:27:09Z","timestamp":1447363629000},"page":"335-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population"],"prefix":"10.1016","volume":"359","author":[{"given":"Soroush","family":"Ehsan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliakbar","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Saeed","family":"Yekaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Mehravar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batoul","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Nafissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jns.2015.11.021_bb0005","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.humimm.2013.08.271","article-title":"Association of HLA-DRB1 14 DRB 16 and DQB1 05 with MuSK-myasthenia gravis in patients from Turkey","volume":"74","author":"Alahgholi-Hajibehzad","year":"2013","journal-title":"Hum. Immunol."},{"issue":"11","key":"10.1016\/j.jns.2015.11.021_bb0010","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0198-8859(01)00320-2","article-title":"Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population","volume":"62","author":"Amirzargar","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jns.2015.11.021_bb0015","doi-asserted-by":"crossref","unstructured":"Avidan, N., Panse, R., Harbo, H.F., Bernasconi, P., Poulas, K., Ginzburg, E., Cavalcante, P., Colleoni, L., Baggi, F., Antozzi, C., Truffault, F., Horn-Saban, S., P\u00f6schel, S., Zagoriti, Z., Maniaol, A., Lie, B.A., Bernard, I., Saoudi, A., Illes, Z., Casasnovas Pons, C., Melms, A., Tzartos,.S, Willcox, N., Kostera-Pruszczyk, A., Tallaksen, C., Mantegazza, R., Berrih-Aknin, S., Miller, A., 2014. VAV1 and BAFF, via NF\u03baB pathway, are genetic risk factors for myasthenia gravis. Ann. Clin. Transl. Neurol., 1, (5) 329\u2013339.","DOI":"10.1002\/acn3.51"},{"issue":"3","key":"10.1016\/j.jns.2015.11.021_bb0020","first-page":"7","article-title":"Determination of HLA-I antigens in patients with myasthenia gravis","volume":"32","author":"Ayromlou","year":"2010","journal-title":"Medical Journal of Tabriz University Of Medical Sciences"},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1998.tb10946.x","article-title":"Identification of a novel HLA class II association with DQB1* 0502 in an Italian myasthenic population","volume":"841","author":"Baggi","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jns.2015.11.021_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2015.11.021_bb0035","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1172\/JCI116110","article-title":"Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus","volume":"90","author":"Caillat-Zucman","year":"1992","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.jns.2015.11.021_bb0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.jns.2015.11.021_bb0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mus.20854","article-title":"Frequency of seronegativity in adult_acquired generalized myasthenia gravis","volume":"36","author":"Chan","year":"2007","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.jns.2015.11.021_bb0050","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.56.4.382","article-title":"Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese","volume":"56","author":"Chen","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2015.11.021_bb0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jns.2015.11.021_bb0060","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/01.WNL.0000032502.89361.0C","article-title":"Thymoma in patients with MG characteristics and long-term outcome","volume":"59","author":"Evoli","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2015.11.021_bb0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1468-1331.2003.00686.x","article-title":"HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis","volume":"10","author":"Garc\u00eda-Ramos","year":"2003","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2015.11.021_bb0070","first-page":"223","article-title":"HLA-DRBI allele frequency in myas thenia gravis patients from southern Iran","volume":"14","author":"Ghaderi","year":"2000","journal-title":"Medical Journal of The Islamic Republic of Iran (MJIRI)"},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.jns.2015.11.021_bb0080","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro\u2192Ala change in TNIP1 and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2015.11.021_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review) report of the quality standards subcommittee of the American academy of neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.11.021_bb0095","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08916939508995300","article-title":"Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis","volume":"22","author":"Hjelmstr\u00f6m","year":"1995","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.jns.2015.11.021_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-5728(96)00008-2","article-title":"Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis","volume":"65","author":"Hjelmstr\u00f6m","year":"1996","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jns.2015.11.021_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis. Recommendations for clinical research standards","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2015.11.021_bb0120","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1212\/WNL.51.4.933-a","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"51","author":"Lindstrom","year":"1998","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2015.11.021_bb0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"The Lancet Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.jns.2015.11.021_bb0130","first-page":"5","article-title":"Pathological aspects of malignant and benign thymic disorders","volume":"31","author":"Muller-Hermelink","year":"1999","journal-title":"Ann. Med. Oct."},{"issue":"2","key":"10.1016\/j.jns.2015.11.021_bb0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1148\/radiology.201.2.8888243","article-title":"Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy","volume":"201","author":"Nicolaou","year":"1996","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.jns.2015.11.021_bb0140","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0002-9394(14)75869-6","article-title":"Penicillamine-induced ocular myasthenia gravis","volume":"99","author":"O'Keefe","year":"1985","journal-title":"Am J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.jns.2015.11.021_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-0039.1993.tb01991.x","article-title":"HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2hours","volume":"41","author":"Olerup","year":"1993","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jns.2015.11.021_bb0155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jns.2015.11.021_bb0165","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","article-title":"A genome-wide association study of myasthenia gravis","volume":"72","author":"Renton","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2015.11.021_bb0170","unstructured":"Roe, B.A., Crabtree, J.S., Khan, A.S., 1995. Methods for DNA isolation. Part III. Protocols for recombinant DNA isolation, cloning, and sequencing [Internet edition]. Norman, OK: University of Oklahoma, 2488\u20132498."},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(00)00415-X","article-title":"True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis","volume":"112","author":"Roxanis","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jns.2015.11.021_bb0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humimm.2006.02.039","article-title":"HLA-DQ polymorphism in Turkish patients with myasthenia gravis","volume":"67","author":"Saruhan-Direskeneli","year":"2006","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.jns.2015.11.021_bb0185","first-page":"125","article-title":"Association between myasthenia gravis and HLA antigens in patients referred to Shafa Hospital, Kerman","volume":"8","author":"Shafa","year":"2004","journal-title":"Medical Journal of Hormozgan University"},{"issue":"2","key":"10.1016\/j.jns.2015.11.021_bb0190","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1399-0039.1991.tb01851.x","article-title":"Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations","volume":"37","author":"Spurkland","year":"1991","journal-title":"Tissue Antigens"},{"issue":"2","key":"10.1016\/j.jns.2015.11.021_bb0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-5728(93)90020-Y","article-title":"The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models","volume":"47","author":"Tournier-Lasserve","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2015.11.021_bb0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2005.09.010","article-title":"Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex","volume":"25","author":"Vandiedonck","year":"2005","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.jns.2015.11.021_bb0205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-5728(93)90021-P","article-title":"Identification of genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis","volume":"47","author":"Vieira","year":"1993","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jns.2015.11.021_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2011.08.023","article-title":"The association of HLA-DQA1* 0401 and DQB1* 0604 with thymomatous myasthenia gravis in northern Chinese patients","volume":"312","author":"Yang","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2015.11.021_bb0215","first-page":"149","article-title":"Association of HLA class I antigens with myasthenia gravis in southern Iran","volume":"22","author":"Yousefipour","year":"1998","journal-title":"Iran J. Med. Sci."},{"issue":"2","key":"10.1016\/j.jns.2015.11.021_bb0220","first-page":"99","article-title":"Association of HLA-DQA1* 0101\/2 and DQB1* 0502 with myasthenia gravis in southern Iranian patients","volume":"6","author":"Yousefipour","year":"2009","journal-title":"Iranian Journal of Immunology: IJI"},{"issue":"4","key":"10.1016\/j.jns.2015.11.021_bb0225","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15300290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15300290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:41:18Z","timestamp":1653525678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X15300290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0022510X15300290"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2015.11.021","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2015.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}